|
Weekly Roundup: 15 Health Press Releases You Need to See
Saturday, March 22, 2025
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including business acquisition news from Sun Pharma and Labcorp as well as new research from the National Sleep Foundation.
NEW YORK, March 14, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.
The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.
1. Sun Pharma to Acquire Checkpoint Therapeutics"We are excited to enter
this transaction with Sun Pharma as the next step to bringing UNLOXCYT to
cSCC [metastatic cutaneous squamous cell carcinoma] patients in need of a
differentiated immunotherapy treatment option," said James Oliviero,
President and Chief Executive Officer of Checkpoint.
2. Labcorp Announces Acquisition of Select Assets of BioReference Health's
Innovative Oncology and Related Clinical Testing Services
BusinessesLabcorp will acquire BioReference Health's laboratory testing
businesses focused on oncology and oncology-related clinical testing
services across the United States. The assets that Labcorp will be
acquiring currently generate approximately $85 million to $100 million in
annual revenue.
3. National Sleep Foundation Research Reveals Nearly 1/3 of Americans
Diagnosed with Sleep Apnea are Not Receiving Treatment Despite Health
Risks Findings revealed 78% of Americans aren't aware of all the
treatment options available for sleep apnea and only 1 in 4 Americans can
identify the health consequences of untreated sleep apnea.
4. Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3
Ignite Study in Adults with Moderate to Severe Atopic DermatitisThe
IGNITE study, which evaluated two dose strengths of rocatinlimab, met its
co-primary endpoints and all key secondary endpoints, achieving
statistical significance for both rocatinlimab dose strengths versus
placebo.
5. Celebrating the Best in Patient Safety: Healthgrades Announces 2025 Top
Hospitals for Patient SafetyThis year's recipients include 442 hospitals
from 40 states and represent the top 10% of hospitals in the nation for
patient safety. Patient safety is a vital component of achieving the best
possible health outcomes, ensuring that serious injuries and
complications are minimized for patients during hospital stays.
6. U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first
and only biosimilar with interchangeability designation referencing
XOLAIR®The availability of the first omalizumab biosimilar will help
increase access and potentially lower the healthcare cost for people with
asthma and allergic diseases.
7. Make-A-Wish Receives $250,000 Grant from U.S. Bank Foundation to Help
Support Life-Changing Wishes Nationwide "Together with the U.S. Bank
Foundation, we look forward to granting wishes that can replace fear with
hope and transform the lives of wish kids and their families," said
Leslie Motter, president and CEO of Make-A-Wish America.
8. Health is Wealth: MyFitnessPal's Third Annual Nutrition IQ Survey Exposes
Americans' Nutritional Blind Spots Amid Rising Food Prices While the new
year traditionally inspires health-oriented resolutions, current economic
pressures are adding a layer of complexity. Rising food prices further
complicate efforts to prioritize nutrient-dense options in grocery carts,
creating a substantial barrier for many.
9. Clayman Thyroid Center Launches Inaugural Hashimoto's Disease Awareness
Day on March 12 Hashimoto's Disease Awareness Day, to be observed
annually on the second Wednesday in March, is designed to bring
much-needed attention to Hashimoto's thyroiditis, an autoimmune condition
that affects millions yet remains misunderstood, underdiagnosed, and
often dismissed.
10. The American Diabetes Association Announces the 2025 National Scientific
and Health Care Achievement Award Winners "The diligent work of these
passionate professionals is moving us closer to a world free of
diabetes. Their contributions to research, prevention, and treatment are
creating lasting change and improving the lives of people affected by
diabetes," said Charles "Chuck" Henderson, the ADA's chief executive
officer.
11. Lilly's baricitinib delivered high rates of hair regrowth for
adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study
"With these data, baricitinib is the most well-studied JAK inhibitor in
severe alopecia areata, a chronic immune system disorder that can have
an especially devastating social and emotional impact on adolescent
patients and their families," said Anabela Cardoso, senior vice
president, Lilly Immunology Medical Affairs.
12. Informa Connect Celebrates Successful HIMSS25, Announces Dates for
HIMSS26 The conference featured 600+ educational sessions, 950+
exhibitors, numerous networking opportunities and a highly attended
hosted buyer program that facilitated crucial conversations about the
future of healthcare technology and delivery models.
13. Data Shows Quality of Life Improves for Spouses of Hip and Knee
Replacement Patients When spouses were surveyed about their own quality
of life compared to before their spouse's surgery, 70% said their
quality of life was slightly or significantly better, 28% noted no
change and 2% reported a slightly worse quality of life.
14. Sesame Place Philadelphia Is First Theme Park in North America to Launch
Hidden Disabilities Sunflower Program Part of a global initiative
designed to support people with non-visible disabilities and conditions,
the program consists of a wearable Sunflower-branded tool that
discreetly signals to Sesame Place Ambassadors that a guest may need
extra help, understanding, or time due to a disability or condition that
may not be immediately apparent.
15. Count Me In Launches New Patient-Partnered Research Project for
Translocation Renal Cell Carcinoma tRCC is a unique type of kidney
cancer caused by specific genetic changes called translocations, where
parts of chromosomes swap places or rearrange. Due to its rarity,
research on tRCC has historically been limited, leaving patients and
families with few therapeutic options and many unanswered questions.
For more news like this, check out all of the latest health-related releases from PR Newswire.
Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.
Helping Journalists Stay Up to Date on Industry News
These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.
Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:
-- Customization: Users can create customized newsfeeds that will deliver
relevant news right to their inbox. Newsfeed results can be targeted by
keywords, industry, subject, geography, and more.
-- Photos and Videos: Thousands of multimedia assets are available to
download and include in a journalist or blogger's next story.
-- Subject Matter Experts: Journalists will have access to ProfNet, a
database of industry experts to connect with as sources or for quotes in
their articles.
-- Related Resources: Our journalist- and blogger-focused blog, Beyond
Bylines, features regular media news roundups, writing tips, upcoming
events, and more.
About PR Newswire
PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.
For questions, contact the team at media.relations@cision.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/weekly-roundup-15-health-press-releases-you-need-to-see-302401521.html
SOURCE PR Newswire
|
|
|
|
|
|
 |
VIAVI Highlights Test Solutions for AI Infrastructure Development, Manufacturing and Deployment at OFC 2025 | Mar 28, 2025
|
|
Oracle Helps Customers Boost Employee Engagement with Strategic Communications and Internal Events | Mar 28, 2025
|
|
ThreatQuotient positioned as a Leader in the SPARK Matrix(TM): Digital Threat Intelligence Management, 2025 by QKS Group | Mar 28, 2025
|
|
Orium Launches Composable Accelerator for Shopify | Mar 28, 2025
|
|
Madame Rachida Dati, French Minister of Culture, has granted official recognition to thierry Ehrmann's Abode of Chaos as a 'total work of art', the global headquarters of Artprice by Artmarket. | Mar 28, 2025
|
|
Datacenter Dynamics Makes History with LoneStar - Becoming the World's First Magazine to Reach the Moon | Mar 28, 2025
|
|
Nosto reports 323% growth of Personalized Search after 2024 Gartner MQ inclusion | Mar 28, 2025
|
|
Western Union forms strategic partnership with HCLTech to transition to an AI led platform operating model | Mar 28, 2025
|
|
Wealthbox Expands to Canada with In-Country Data Hosting | Mar 28, 2025
|
|
Direct Digital Holdings Launches "Practical Generative AI Use Cases & Tools for DMOs" to Help Break New Ground in Destination Marketing With AI | Mar 28, 2025
|
|
|
|
